Effects of coronary artery by-pass grafting on haemostatic factors

Piotr Lisowski1, Jolanta Małyszko, Ryszard Jackowsk

  • 1Department of Cardiac Surgery, Medical Academy, Białystok, Poland.

Kardiologia Polska
|April 30, 2004
PubMed

Insights

Coronary artery bypass grafting (CABG) increases hypercoagulability in patients with coronary artery disease (CAD). The procedure significantly elevates von Willebrand factor (vWF), indicating endothelial injury from extracorporeal circulation.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Surgical Research

Background:

  • Atherogenesis involves endothelial injury, leading to alterations in humoral and secretion functions.
  • The hemostatic system is crucial in the development of atherosclerosis and acute coronary syndromes.

Purpose of the Study:

  • To evaluate the impact of coronary artery bypass grafting (CABG) on specific hemostatic factors in patients with stable coronary artery disease (CAD).

Main Methods:

  • The study included 45 patients undergoing CABG and 33 healthy controls.
  • Measurements of von Willebrand factor (vWF), thrombin-antithrombin complexes (TAT), and prothrombin fragments (F1+2) were taken pre-CABG and at 3 days, 7 days, and 3 months post-CABG.

Main Results:

  • Patients undergoing CABG exhibited significantly higher levels of vWF, TAT, and F1+2 compared to controls.
  • vWF levels were notably elevated 3 and 7 days after CABG compared to baseline.

Conclusions:

  • Patients with CAD undergoing CABG experience a state of hypercoagulability.
  • The use of extracorporeal circulation during CABG results in significant endothelial injury, evidenced by increased vWF levels.
Abstract